Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6800-0.1000 (-5.62%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/5/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
42.57M66.11M98.62M106.02M83.60M
Enterprise Value
1.57M21.05M50.59M84.81M60.30M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.041.502.105.223.61
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-0.12-5.96-15.61-24.87-17.95

Trading Information

Stock Price History

Beta (5Y Monthly) 2.10
52-Week Change 3-47.80%
S&P500 52-Week Change 3-6.69%
52 Week High 34.8200
52 Week Low 31.1500
50-Day Moving Average 31.8854
200-Day Moving Average 32.7734

Share Statistics

Avg Vol (3 month) 3139.67k
Avg Vol (10 day) 352.97k
Shares Outstanding 526.44M
Implied Shares Outstanding 6N/A
Float 817.41M
% Held by Insiders 126.23%
% Held by Institutions 124.08%
Shares Short (Jul 14, 2022) 448.36k
Short Ratio (Jul 14, 2022) 40.16
Short % of Float (Jul 14, 2022) 40.19%
Short % of Shares Outstanding (Jul 14, 2022) 40.18%
Shares Short (prior month Jun 14, 2022) 450.19k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 14, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.47%
Return on Equity (ttm)-42.18%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.54M
Net Income Avi to Common (ttm)-13.48M
Diluted EPS (ttm)-0.5940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.05M
Total Cash Per Share (mrq)1.55
Total Debt (mrq)43k
Total Debt/Equity (mrq)0.10
Current Ratio (mrq)29.37
Book Value Per Share (mrq)1.54

Cash Flow Statement

Operating Cash Flow (ttm)-11.83M
Levered Free Cash Flow (ttm)-7.09M
Advertisement
Advertisement